Summary: Featuring articles on tafamidis for transthyretin amyloid cardiomyopathy, fingolimod vs. interferon for pediatric MS, residual disease in myelodysplastic syndrome, BRCA2 and ovarian development, and prostate cancer and checkpoint inhibition; review articles on primary hyperparathyroidism and on aspirin-exacerbated respiratory disease; a case report of a man with epistaxis, pain and erythema of the forearm, and pancytopenia; and Perspective articles on the tobacco Master Settlement Agreement, on regulating drug prices, and to be guided by instinct.
